| Product NDC: | 0066-7150 |
| Proprietary Name: | Carac |
| Non Proprietary Name: | fluorouracil |
| Active Ingredient(s): | 5 mg/g & nbsp; fluorouracil |
| Administration Route(s): | TOPICAL |
| Dosage Form(s): | CREAM |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0066-7150 |
| Labeler Name: | Dermik Laboratories |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA020985 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20001027 |
| Package NDC: | 0066-7150-30 |
| Package Description: | 30 g in 1 TUBE (0066-7150-30) |
| NDC Code | 0066-7150-30 |
| Proprietary Name | Carac |
| Package Description | 30 g in 1 TUBE (0066-7150-30) |
| Product NDC | 0066-7150 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | fluorouracil |
| Dosage Form Name | CREAM |
| Route Name | TOPICAL |
| Start Marketing Date | 20001027 |
| Marketing Category Name | NDA |
| Labeler Name | Dermik Laboratories |
| Substance Name | FLUOROURACIL |
| Strength Number | 5 |
| Strength Unit | mg/g |
| Pharmaceutical Classes | Nucleic Acid Synthesis Inhibitors [MoA],Nucleoside Metabolic Inhibitor [EPC] |